The Board proposes the rule amendment to update language regarding licensure by endorsement application for pharmacists and pharmacy technician registration.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-26.204Pharmacist Licensure by Endorsement; Application

PURPOSE AND EFFECT: The Board proposes the rule amendment to update language regarding licensure by endorsement application for pharmacists and pharmacy technician registration.

SUMMARY: Language regarding licensure by endorsement application for pharmacists and pharmacy technician registration will be updated.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board concluded that this rule change will not have any impact on licensees and their businesses or the businesses that employ them. The rule will not increase any fees, business costs, personnel costs, will not decrease profit opportunities, and will not require any specialized knowledge to comply. This change will not increase any direct or indirect regulatory costs. Hence, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.013, 465.005, 465.0075 FS.

LAW IMPLEMENTED: 456.013(1), (2), 456.0635, 465.007, 465.0075 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Traci Zeh, Acting Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C08, Tallahassee, Florida 32399-3258 or by email at [e-mail].

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

Substantial rewrite of Rule 64B16-26.204 follows. See Florida Administrative Code for present text.

64B16-26.204 Pharmacist Licensure and Pharmacist Technician Registration by Endorsement; Application.

(1) An applicant for licensure by endorsement pursuant to section 456.0145(2), F.S., shall submit as part of his or her application DH-MQA-5103 (eff. 08/2024), “Mobile Opportunity by Interstate Licensure Endorsement” which is incorporated herein by reference and which may be obtained from https://www.flrules.org/Gateway/reference.asp?No=Ref-             , the Board office, or at www.floridaspharmacy.gov. An applicant for licensure by endorsement must also demonstrate compliance with the criteria set forth in section 456.0145(2), F.S., prior to the issuance of the license.

(2) Applicants shall cause the National Association of Boards of Pharmacy, or other similar organization, to issue a Transfer of Pharmaceutical Licensure certificate showing examination date and examination results.

Rulemaking Authority 456.013, 456.0145, 465.005, 465.0075 FS. Law Implemented 456.013(1), (2), 456.0145, 456.0635, 465.007, 465.0075 FS. History–New 11-8-01, Amended 1-11-05, 2-18-08, 5-26-09, 10-10-10, 1-10-17, 12-29-21,                        .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: August 22, 2024

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: September 24, 2024